help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Knox, K. L.
Right arrow Articles by Schwartz, N. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Knox, K. L.
Right arrow Articles by Schwartz, N. B.

Endocrinology, Vol 133, 277-283, Copyright © 1993 by Endocrine Society

ARTICLES

RU486 blocks the effects of inhibin antiserum or luteinizing hormone on the secondary follicle-stimulating hormone surge

KL Knox, SJ Ringstrom and NB Schwartz
Department of Neurobiology and Physiology, Northwestern University, Evanston, Illinois 60208.

Previous work in this laboratory has shown that when the antiprogesterone RU486 is administered at 1230 h on proestrus, the primary surges of LH and FSH are significantly attenuated, and the secondary FSH surge is abolished. This suppression of the secondary FSH surge occurs in RU486-treated rats despite a drop in serum inhibin, which is presumably due to the partial primary LH surge. The experiments described investigated the interrelationships among the primary LH surge, the rising proestrous levels of progesterone, and the falling levels of inhibin on proestrus on the selective secretion of FSH during the night of proestrus and the morning of estrus. Exogenous LH given to rats treated first with RU486 cannot restore the secondary surge of FSH, as it does in GnRH antagonist-blocked rats, and progesterone alone cannot restore the secondary FSH surge in an animal in which the surges are blocked with GnRH antagonist. Antiserum to inhibin superimposed on GnRH antagonist causes an enhancement of FSH levels beyond that of the secondary FSH surge, but antiserum to inhibin superimposed on RU486 does not induce a similar elevation of FSH secretion. The failure of antiserum to inhibin to increase FSH in the face of RU486 suggests that either a small amount of progesterone, or perhaps another hormone blocked by RU486, is needed to facilitate FSH secretion in response to the drop in inhibin or RU486 is acting through nonprogesterone-mediated effects to block pituitary FSH secretion.


This article has been cited by other articles:


Home page
 Endocr. Rev.Home page
R. M. Sapolsky, L. M. Romero, and A. U. Munck
How Do Glucocorticoids Influence Stress Responses? Integrating Permissive, Suppressive, Stimulatory, and Preparative Actions
Endocr. Rev., February 1, 2000; 21(1): 55 - 89.
[Abstract] [Full Text]

Home page
 Mol. Endocrinol.Home page
A. Mukherjee, J. Urban, P. Sassone-Corsi, and K. E. Mayo
Gonadotropins Regulate Inducible Cyclic Adenosine 3',5'-Monophosphate Early Repressor in the Rat Ovary: Implications for Inhibin {alpha} Subunit Gene Expression
Mol. Endocrinol., June 1, 1998; 12(6): 785 - 800.
[Abstract] [Full Text]

Home page
 EndocrinologyHome page
S. J. Ringstrom, M. Szabo, S. M. Kilen, S. Saberi, K. L. Knox, and N. B. Schwartz
The Antiprogestins RU486 and ZK98299 Affect Follicle-Stimulating Hormone Secretion Differentially on Estrus, but not on Proestrus
Endocrinology, June 1, 1997; 138(6): 2286 - 2290.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1993 by The Endocrine Society